
Compared with placebo, maximal
walking distance for cilostazol and
pentoxifylline increased by 25% (11
to 40 m) and 11% (e1 to 24 m),
respectively. Pain-free walking distance
increased by 13% and 9%, respectively

A-B

B

A

A for cilostazol
and B for
pentoxifylline
(imprecision)

